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Elevated levels of air pollution particulate
matter (PM) in the inhalable size range (< 10
µm in diameter) are associated with increased
hospitalization for respiratory disease, includ-
ing pneumonia and asthma (1–3). Most
recently, the concentration of particles in the
size range < 2.5 µm diameter (PM2.5) has
been suggested to be the most important
determinant in pollution particle–induced
health effects (4,5). The causative con-
stituents of PM and the pathophysiologic
mechanisms related to such health problems
have not been determined. Part of this uncer-
tainty regarding mechanism arises from the
difﬁculty of exposing humans and animals to
particles considered to be equivalent to those
inhaled by populations included in the epi-
demiologic studies. Particles collected from
specific emission sources such as residual oil
ﬂy ash and diesel, as well as water extracts of
ambient air particles, have been demonstrated
to cause an inﬂux of neutrophils into the lung
in both animals and humans (6–8).
Furthermore, diesel particles have been
shown to divert the immune response toward
an allergic phenotype (9,10). In vitro studies
with urban air particles have been shown to
alter alveolar macrophage function in a man-
ner promoting survival of microbes (11–13).
However, this effect on macrophages resides
in the coarse particle fraction (2.5–10 µm)
rather than in the ﬁne fraction (14,15).
The recent development of ambient particle
concentrators has made it possible to perform
controlled exposures of animals and humans
by inhalation of real-world particles. In the
present study we describe the effects of expo-
sure of healthy individuals to concentrated
PM2.5 found in the air in Chapel Hill, North
Carolina, on function and phenotype of
immune cells in the lung and blood. The parti-
cles were concentrated 6- to 10-fold and vol-
unteers were exposed to levels ranging from 23
µg/m3 to 311 µg/m3. These levels approximate
the total levels of particles found in many met-
ropolitan areas of the United States. Because
increased incidence of asthma severity, allergy,
and pneumonia can be associated with PM
levels, we assessed various host defense parame-
ters involved in regulating these diseases,
including immune cell phenotype, alveolar
macrophage (AM) function and inﬂammation.
Materials and Methods
Ambient Aerosol Exposure System
Particles between the sizes of 0.1 and 2.5
microns present in the Chapel Hill air were
concentrated using a Harvard/EPA ambient
ﬁne particle concentrator (HAPC) consisting
of three-stage virtual impactors. The princi-
ples by which this concentrator works have
been previously described (16,17). A
schematic of the concentrator and human
exposure chamber is provided (Figure 1). The
concentrator uses the inertial separator tech-
nique, thus concentrating particles only, not
gases. Briefly, outside air is first drawn
through an Anderson high-volume conven-
tional impactor with a 2.5-µm cut-off size at
a rate of 5,000 L/min. The exit ﬂow from the
Anderson impactor, which contains particles
mainly < 2.5 µm in diameter, is drawn into
the first stage of the concentrator in which
five virtual impactor slits (1,000 L/min/slit)
are arranged in parallel. The virtual impactor
consists of two parts: The upper part is in the
form of a rectangular nozzle through which
airﬂow is accelerated, and the lower part is in
the form of a sharp-edged slit that receives
incoming particles. Each virtual impactor
operates at a minor-to-total ﬂow ratio of 0.2
so that 80% of airﬂow leaving the rectangular
nozzle is deflected to the side stream (i.e.,
major ﬂow) and 20% of the ﬂow is extracted
straight down into the receiving slit (i.e.,
minor flow). In this design, particles > 0.1
µm achieve sufficient momentum to cut
across the deflecting major flow stream and
enter the receiving slit, whereas particles < 0.1
µm follow the major stream and are
exhausted. For this reason, particles smaller
than 0.1 µm are not concentrated. Ideally, if
all particles between 0.1 and 2.5 µm are
We tested the hypothesis that exposure of healthy volunteers to concentrated ambient air
particles (CAPS) between 0.1 and 2.5 µm in diameter is associated with modulation of human
alveolar macrophage (AM) function, cytokine production, and immune phenotype in both blood and
lung. Thirty-eight volunteers were exposed to either ﬁltered air or CAPS from the immediate
environment of the U.S. Environmental Protection Agency human studies facility in Chapel Hill,
North Carolina, USA. Particle concentrations in the chamber during the exposures ranged from
23.1 to 311.1 µg/m3. No symptoms were noted by volunteers after the exposure. Eighteen hours
after exposure, analysis of cells obtained by bronchoalveolar lavage (BAL) showed a mild increase
in neutrophils in both the bronchial (8.4 ± 2%) and alveolar fractions (4.2 ± 1.7%) in subjects
exposed to the highest concentration of CAPS compared to neutrophils in the ﬂuids of those
exposed to ﬁltered air (bronchial fraction 2.7 ± 0.6%; alveolar fraction 0.8 ± 0.3%). There was no
change in the percentage of lymphocytes or AMs recovered in the lavage after inhalation of the
highest particle levels (mean 207 µg/m3). There was also no change in the proportion of
lymphocytes in the BAL expressing CD3, CD4, CD8, CD19, nor activation markers CD25 or CD69.
Particle inhalation did not affect the expression of CD11b, CD64, CD16, CD14, CD71 on AM, nor
was there an effect on phagocytosis or oxidant generation following stimulation with zymosan A.
IL-6 and IL-8 levels detected by enzyme-linked immunoabsorbent assay in the BAL were unrelated
to inhaled particle levels. The distribution of lymphocyte subsets in blood obtained 18 hr after
exposure to CAPS did not differ from that found before exposure. We conclude that ambient air
particles are capable of inducing a mild inﬂammation in the lower respiratory tract but have no
effect on immune phenotype or macrophage function under the conditions tested. Key words: air
pollution particles, alveolar macrophages, bronchoalveolar lavage, cytokines, lymphocytes, oxidant
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condensed into the minor flow, particle
concentration in the minor ﬂow will increase
5 times. In the present system, particles rang-
ing in size from 0.1 to 2.5 µm are concen-
trated about 2.5- to 3-fold in the first stage,
and a combined ﬂow from ﬁve receiving slits
(minor ﬂow) is drawn into the second stage at
the rate of 1,000 L/min. The second stage
consists of a single virtual impactor identical
to those in the ﬁrst stage. Here, particles are
concentrated 2.5- to 3-fold again and drawn
into the third stage at the rate of 200 L/min.
A single virtual impactor in the third stage
operates at a minor-to-total ﬂow ratio of 0.4
and concentrates particles about 2-fold at a
flow rate of 80 L/min. Finally, the concen-
trated aerosols leaving the third stage are
mixed with 120 L/min clean and conditioned
air (20°C and 50% relative humidity), and
the resulting conditioned aerosols are deliv-
ered into the exposure chamber at the rate of
200 L/min. The addition of the conditioned
air dilutes the concentrated aerosols, but pro-
vides consistent temperature and humidity
and allows sufficient airflow for subjects to
exercise during exposure. In this study, parti-
cles were concentrated 6- to 10-fold at the
inlet of the chamber. 
A controlled exposure to air with no PM
was required. Subsequently, ﬁltered air (con-
taining no metals, carbon, sulfates, or
nitrates) was employed. Sham exposures were
conducted using 200 L/min conditioned air
and no air from the HAPC. Outside air was
drawn in across beds of activated charcoal
and potassium permanganate on alumina.
After heating to 550°F to remove bound
organics, the air was passed over cooling coils
to a ﬁnal temperature of 58°F. After passage
through a series of HEPA ﬁlters, the air was
introduced into the particle chamber. 
The maximum concentration of aerosols
to be delivered to the chamber varied depend-
ing on concentrations of naturally occurring
PM2.5 in the Chapel Hill air (which usually
ranges from 5 to 30 µg/m3). The exposure
chamber is 4.0 × 6.7 × 7.5 ft and constructed
with aluminum panels and heavy-duty clear
plexiglass for doors and windows. Because the
air-pumping units are located downstream of
the chamber and the HAPC, the chamber is
operated under a slightly negative pressure
(10–12 inches of water). Aerosols enter the
chamber via a 6-inch diameter curved duct
positioned on the top and middle of the
chamber and exit via an exhaust duct posi-
tioned in the middle of one of the vertical
walls (Figure 1). The subject sits between the
inlet and exit duct with subject’s head located
less than 18 inches away from the inlet duct.
A series of tests conducted in the present
study have shown that the particle concentra-
tion at the subject’s head position is at least
90% of that at the inlet duct.
Particle Characterization
Air was sampled just prior to entering the
HAPC and again just before entering the
chamber from the inlet duct. Particles were
collected on preweighed 47-mm Teﬂon ﬁlters
(2-µm pore, Gelman Sciences, Ann Arbor,
MI, USA) at a ﬂow rate of 10 L/min for 2 hr
during the exposure. Filters were weighed on
an electrobalance (Mettler UMT2, Mettler
Instruments, Columbus, OH, USA) in a
temperature- (20°C) and humidity- (45%)
controlled room. This balance can reliably
weigh masses as low as 1 µg. The end net ﬁl-
ter weight, sampling time, and ﬂow rate were
used to calculate the particle concentration in
micrograms per cubic meter. Filters with
sequestered PM (both before and after con-
centration) were analyzed for a number of
components, including transition metals, ele-
mental and organic carbon, sulfates, and
nitrates. There were no appreciable differ-
ences in chemical composition of particles
before and after concentration. 
The particle size distribution was obtained
using a micro-orifice uniform deposit
impactor (MOUDI, MSP Corporation,
Minneapolis, MN, USA), which is an
eight-stage cascade impactor containing a
series of micro-oriﬁces that collect particles on
preweighed 37-mm Teﬂon ﬁlters (2-µm pore,
Gelman Sciences, Ann Arbor, MI, USA).
Aerosols were sampled from the inlet duct at a
ﬂow rate of 30 L/min for 2 hr. The ﬁlter sub-
strates from the impactor were weighed under
a controlled environment following the same
procedure described above for total ﬁlter sam-
ples. The weights from each stage were used
to determine the mass median aerodynamic
diameter (MMAD) and the geometric stan-
dard deviation (GSD). These data are
reported in Table 1. In addition, ozone was
measured inside the exposure chamber; con-
centrations did not exceed 0.05 ppm. 
Study Population
Volunteers responding to a newspaper adver-
tisement were prescreened over the telephone
using the following criteria: age between 18
and 40 years of age; nonsmokers for at least 5
years prior to study; no history of allergies or
respiratory diseases (food allergy, hay fever,
dust allergies, rhinitis, asthma, chronic bron-
chitis, chronic obstructive pulmonary disease,
tuberculosis, hemoptysis, or recurrent pneu-
monia); and not presently on any medication
prescribed by a physician (except birth con-
trol pills). A urine pregnancy test was per-
formed on all female subjects and a positive
result excluded the subject from further par-
ticipation in this study. The average age of
the subject population was 26.2 ± 0.7 years
and included 38 volunteers of which 36 were
males and 2 were females. 
Exposure to Concentrated Air Particles
Each volunteer had a single exposure to either
ﬁltered air or concentrated air particles (CAPS).
Total exposure time was 2 hr. Subjects entered
the exposure chamber and sat on a recumbent
bicycle ergometer. Subjects exercised for 30
min of each hour. The schedule of exercise was
15 min on a cycle ergometer, 15 min rest, and
this was repeated 4 times. Exercise intensity,
i.e., cycle ergometer workload, was adjusted so
subjects breathed at a ventilatory rate, normal-
ized for body surface area, of 25 L/m2/minute.
In most subjects this will be about 50 L/min
[i.e., a oxygen consumption (VO2) of approxi-
mately 1.0 L/min]. A cycle ergometer work set-
ting of 75–100 watts achieved such a
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Figure 1. Schematic diagram of the Harvard/EPA
ambient ﬁne particle concentrator.
Table 1. Physical characterization of particles.
Quartile 1a Quartile 2 Quartile 3 Quartile 4 Total CAPS
Number of subjects 8 10 10 10 30
PM2.5 after concentrator (µg/m3) 47.2 ± 5.3 107.4 ± 9.3 206.7 ± 19.2 120.4 ± 14.1
PM2.5 before concentrator (µg/m3)9 .9 ± 3.0 30.3 ± 3.8 37.6 ± 4.6 26.4 ± 3.0
Concentration factor 9.4 ± 2.3 4.1 ± 0.7 6.4 ± 1.0 6.5 ± 0.9
MMAD (microns) 0.54 ± 0.06 0.67 ± 0.05 0.72 ± 0.03 0.65 ± 0.028
GSD of MMAD 2.44 ± 0.16 2.39 ± 0.14 2.24 ± 0.084 2.35 ± 0.72
(δ g) 
aClean air.Concentrated ambient particles and humans
physiologic response for most subjects. During
the 2-hr exposure, particle concentrations were
monitored continuously at the inlet duct of the
chamber by using a tapered element oscillating
microbalance [(TEOM), Series 1400a,
Rupprecht & Patashnick, Inc., Albany, NY,
USA]. The TEOM was used to monitor a con-
sistency or short-term excursion of exposure
concentration. The average exposure concen-
trations were determined by ﬁlter samples as
described above.
Bronchoscopy with Lavage
Using a standard protocol (18), the volunteers
underwent bronchoscopy with lavage 18 hr
after exposure to either ﬁltered air or CAPS.
Previous investigation in both animals and
humans indicated that an inflammatory
response resulted between 18 and 24 hr after
exposure to particles (6,7). The fiberoptic
bronchoscope was wedged into a segmental
bronchus of the lingula. Following instillation
and aspiration of a 20-mL bronchial sample
(BL), three 50-mL aliquots of sterile saline
were instilled and immediately aspirated to
obtain the bronchoalveolar wash (BAL). The
procedure was repeated on the right middle
lobe. Samples were put on ice immediately
after aspiration and centrifuged at 300× g for
10 min at 4°C. Cells were washed once with
RPMI medium and viability determined via
trypan blue exclusion. Viability exceeded
85% in all samples and there was no differ-
ence between air- and CAPS-exposed individ-
uals. Cell numbers were determined using a
hemacytometer. Cell differentials were per-
formed on cytocentrifuged slides stained with
a modiﬁed Wright Stain (Leukostat Solution,
Fisher Scientific, Suwannee, GA, USA). At
least 200 cells per slide were counted. There
was no difference in recovery of BL or BAL
fluid between air- and CAPS-exposed indi-
viduals, and all fluid recoveries were within
10% of one another. Consequently, soluble
components were normalized per milliliter of
ﬂuid. Interleukin (IL)-8 and IL-6 levels were
measured using enzyme-linked immuno-
absorbent assay (ELISA) kits purchased from
R&D Systems (Minneapolis, MN, USA). 
Staining and Analysis of Cells in Lung
and Blood
Venous blood was collected into heparinized
vacutainers immediately before and 18 hr
after the exposure. Heparinized whole blood
or lavage fluid was mixed with fluorescein
isothiocyanate (FITC) or phycoerythrin con-
jugated monoclonal antibodies (Coulter
Corp., Miami, FL, USA) according to manu-
facturer’s recommended procedures for direct
staining. Blood was then lysed with fluores-
cent-activated cell sorter [(FACS); Becton
Dickinson, San Jose, CA, USA] lysing solu-
tion, washed, and fixed in 0.5%
paraformaldehyde. Stained cell preparations
were held at 4°C until analyzed. Analysis was
performed using a Becton Dickinson
FACSort equipped with a 488-nm laser. Cell
populations were identiﬁed and gated on the
basis of forward and side scatter characteris-
tics. Cell Quest software (Becton Dickinson,
Version 3.1) for analysis of cell surface
marker expression was employed. 
Characteristics of antibodies selected for
immunofluorescence staining of cell surface
membrane markers are described in Table 2.
Isotypic controls of immunoglobulin G sub-
classes corresponding to these antibodies were
included for setting gates and 10,000 counts
per sample were analyzed.
Phagocytosis
Saccharomyces cerevisiae zymosan A or
Staphylococcus aureus bacteria (Bioparticles;
Molecular Probes, Inc., Eugene, OR, USA)
conjugated to FITC were prepared per manu-
facturer directions. AM (2 × 105) from
exposed individuals were incubated with 10×
bioparticles for 1 hr at 37°C/5% CO2 before
being placed on ice and immediately analyzed
for bioparticle uptake by FACSort. Percent
phagocytosis and mean ﬂuorescence was ana-
lyzed by assessing the bioparticle uptake in
the CAPS-exposed AM population compared
to ﬁltered air control AM. 
Oxidant Generation
Oxidant generation was measured via chemi-
luminescence performed on a Berthold
LB953 autolumat (Perkin Elmer, Norwalk,
CT, USA). Human AM (105 cells in 100 µL
RPMI without phenol red) or 100 µL blood
diluted 1:10 into Hank’s balanced salt solu-
tion (HBSS) (Sigma, St Louis, MO, USA)
and 600 µL luminol reagent (0.15 mM lumi-
nol, 1.3 mM calcium chloride, 135 mM
sodium chloride, 5 mM morpholino-
ethanesulfonic acid, 0.4 mM magnesium
chloride, 0.5 mM magnesium sulfate, 0.8
mM sodium phosphate monobasic, and 5.5
mM D-glucose) (pH 7.2) (Sigma) were
injected simultaneously into tubes containing
10× human serum opsonized zymosan A
(Sigma). Resultant chemiluminescence was
measured over a 30-min period. The data are
expressed as integrated chemiluminescence
counts.
Statistics
Data are expressed as mean values ± standard
error. Differences between air- and CAPS-
exposed groups were tested using the t test of
independent means. For those variables that
were signiﬁcantly altered, the population was
divided into quartiles and differences between
groups were compared using one-way analysis
of variance (ANOVA) (19). The post hoc test
employed was Scheffe’s test. Two-tailed tests
of significance were employed. Significance
was assumed at p < 0.05.
Results 
Study Population and Exposure
The subject population included 38 volunteers
(26.2 ± 0.7 years of age; 36 males and 2
females). There were eight exposures to fil-
tered air (PM mass by measured filtered
weights of 2.9 ± 1.9 µg/m3) and 30 exposures
to CAPS (PM mass of 120.5 ± 14.0 µg/m3).
There was a substantial range in CAPS expo-
sures, reﬂecting the variation in particles out-
side the facility (Table 1), with individual
exposures ranging from 23 to 311 µg/m3.
Considering time of exposure and ventilation
rates, we estimate that individual lung expo-
sures approximated a total dose of 1,200 µg
on those days with the highest PM mass. The
study population was divided into quartiles,
with the eight individuals exposed to ﬁltered
air deﬁning the ﬁrst quartile (quartile 1) and
the remaining 30 exposures arranged into
groups of 10 with ascending PM mass (quar-
tiles 2, 3, and 4). Differences between the
quartiles in PM mass were significant (F =
41.2; p < 0.0001). Excluding air exposures,
the concentration factor was 6.5 ± 0.9. There
were differences (F = 3.6; p = 0.04) between
the concentration factors with post hoc test-
ing revealing significance only between the
second and third quartiles. Measurement of
iron, zinc, and sulfur by x-ray fluorescence
verified concentration factors that approxi-
mated the value for total mass (8.5 ± 4.4,
10.8 ± 3.9, and 6.8 ± 1.4, respectively). The
size distribution of exposure aerosols was
approximately log normal, with the values of
MMAD and GSD being 0.65 ± 0.03 and
~2.35, respectively. There was a slight
increase in MMAD from 0.54 to 0.72 µm
with an increase in mass concentration from
quartile 2 to quartile 4. 
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Table 2. Surface markers investigated on lymphocytes.
Marker Expression Marker Expression
CD45 All leukocytes HLA-DR Activated T lymphocytes
CD19 B lymphocytes CD45RO Memory lymphocytes
CD3 T lymphocytes CD25 Activated T and B (IL-2 )
CD4 T-helper cells CD69 Activated T, B lymphocytes and macrophages
CD8 T-suppressor cells
CD16 NK cells CD56 NK cells
NK, natural killer.Harder et al.
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Changes in Bronchoalveolar Lavage
Fluid and Cells
Inﬂammation. Total cells found in BAL ﬂuid
were increased in those individuals exposed to
CAPS (Table 3). Individuals exposed to air
had 15.9 ± 1.9 × 106 cells, whereas those
exposed to CAPS had 21.4 ± 1.3 × 106 cells
(p = 0.04). The percentage of macrophages,
lymphocytes, monocytes, and epithelial cells
were not increased after CAPS exposure.
However, the percentage of neutrophils sig-
nificantly increased following particle expo-
sure (2.5 ± 0.6 for CAPS and 0.8 ± 0.3 for
air; p = 0.016). In addition, absolute numbers
of neutrophils were increased in BAL fluid
following CAPS exposure (0.56 × 106) as
compared with air exposure (0.09 × 106) (p =
0.0013). Neutrophil influx appeared to be
dependent on dose, with the greatest eleva-
tions occurring in the those subjects exposed
to the highest concentration of particles (F =
2.9; p = 0.05).
Lymphocytes. BAL lymphocytes from
individuals exposed to CAPS and ﬁltered air
were stained with antibodies recognizing
mature T cells (CD3), T-helper cells (CD4),
T-suppressor cells (CD8), B cells (CD19),
NK cells (CD56), and lymphocyte activation
marker, the IL-2 receptor CD25. The results
of the flow cytometric analysis of percent of
cells positive for each of the markers are
shown in Table 4. The data are presented in
quartiles of CAPS concentration in the expo-
sure chamber. It was apparent that inhalation
of particles had no effect on lymphocyte sub-
sets obtained by lavage. The early lymphocyte
activation marker CD69 (not shown) was also
assessed with negative results (not shown).
Alveolar macrophages. The expression of
cell-surface receptors involved in host defense
against microbes complement receptor/
β -integrin CD11b, the endotoxin receptor
CD14, and Fc receptors CD16 and CD64
were analyzed on AM 18 hr following particle
inhalation. As in the results with lymphocyte
markers, the surface receptor data are pre-
sented as a function of PM mass expressed in
quartiles. The data are shown in Table 5.
There was no change in receptor expression
even at the highest PM levels. Phagocytosis
of both FITC-conjugated bacteria and yeast
particles (Table 6) was performed on AM
from air- or CAPS-exposed subjects. The
range of uptake of bacterial particles was
85.5–92.5% in all quartiles whereas yeast
particle uptake ranged from 50 to 67%
(Table 6). CAPS did not affect phagocytosis
of either bacteria or yeast by AM. Oxidant
generation by AM exposed to air or CAPS
was measured in a luminol assay using
human serum opsonized yeast particle as the
oxidant stimulant (Table 6, bottom). As with
phagocytosis, there was no signiﬁcant differ-
ence in the chemiluminescence response
between CAPS and air exposure.
Cytokines. Concentrations of IL-6 and
IL-8 in the BAL were analyzed by ELISA
(Table 7). Interestingly, IL-8 levels were con-
siderably lower in the most heavily exposed
individuals (66.4 ± 21.7 pg/mL) compared
with those exposed to air (288.8 ± 109.6
pg/mL), although these differences did not
reach statistical signiﬁcance.
Changes in Blood
Blood was obtained before and 18 hr post-
exposure. Blood cell differentials and total cell
counts per milliliter did not change following
CAPS exposure (Table 8). Lymphocyte cell-
surface markers CD3, CD4, CD8, CD19,
and CD56 were analyzed pre- and 18 hr
post-CAPS inhalation. The proportions of
lymphocyte subsets did not change with
CAPS exposure nor was there evidence of
activation measured by CD69 expression on
the leukocyte populations (Table 9). 
Chemiluminescence generation by blood
granulocytes and monocytes in response to
opsonized zymosan stimulation is a sensitive
method of assessing activation of these cells. In
the subjects exposed to CAPS, no effect on this
host defense parameter was found (Table 10).
Discussion
This study demonstrates that in young,
healthy volunteers exposed to ambient air
particles, a small increase in neutrophils can
be found in the lower respiratory tract, but
that no effect of particle inhalation could be
found involving the cellular immune system.
The highest concentration of PM2.5 employed
in this investigation, 311 µg/m3 and a mean
of 207 µg/m3 in the highest exposure quar-
tile, would be an uncommon level of fine
particles to be encountered in this country.
However, the total exposure for individuals
living in environments with much lower
PM2.5 levels would still be greater than that
to which these volunteers were exposed for 2
hr, as a resident of any urban area in the
United States will be exposed to elevated
particle levels all through the day. The inﬂux
of neutrophils into the lung of CAPS-
exposed individuals was dose dependent,
with those subjects exposed to the highest
concentration of CAPS having the most
neutrophils. The number of neutrophils pre-
sent in BAL fluid was comparable to that
found in healthy young volunteers exposed
to low levels (0.10 ppm) of ozone for several
hours (20). Neutrophils present in the BL of
humans exposed to CAPS were also similar
quantitatively to those found after human
exposure to 300 µg/m3 diesel exhaust for 1
hr (7). Although the latter study did not
observe increased neutrophils in the alveolar
fraction, this disparity may be explained by
the differences in particle composition or
source, timing of bronchoscopy (6 hr
Table 3. Bronchoalveolar lavage cells following CAPS exposure.
Quartile 1 (air) Quartile 2 Quartile 3 Quartile 4 Total CAPS
PM2.5 47.2 ± 5.3 107.4 ± 9.3 206.7 ± 19.2 120.4 ± 14.1
Total count (× 106) 15.9 ± 1.9 20.3 ± 3.0 23.0 ± 2.1 20.8 ± 2.0 21.4 ± 1.3*
Macrophages (%) 80.6 ± 2.9 82.4 ± 2.2 82.9 ± 1.3 75.4 ± 3.7 80.2 ± 1.6
Neutrophils (%) 0.8 ± 0.3 1.4 ± 0.4 2.0 ± 0.4 4.2 ± 1.7 2.5 ± 0.6*
Lymphocyte (%) 16.8 ± 2.4 13.1 ± 1.7 13.1 ± 1.3 19.0 ± 3.1 15.1 ± 1.3
Monocytes (%) 1.2 ± 0.3 0.9 ± 0.2 1.3 ± 0.3 2.2 ± 0.5 1.4 ± 0.2
Epithelial cells (%) 1.3 ± 0.3 0.8 ± 0.1 0.8 ± 0.1 1.4 ± 0.3 1.1 ± 0.1
*p < 0.05. 
Table 4. Lymphocyte subpopulations in BAL following
CAPS exposure.
Percent of gated lymphocytes
Quartile 1 (air)a Quartile 2 Quartile 3 Quartile 4
CD3  85 ± 3 78 ± 2  69 ± 6 80 ± 5
CD19 2 ± 0.5 2 ± 0.4 2 ± 0.3 2 ± 0.4
CD4 48 ± 5 45 ± 6 36 ± 5 51 ± 8
CD8 39 ± 5 33 ± 4 31 ± 6 33 ± 5
CD56 4 ± 1 6 ± 2 4 ± 1 5 ± 1
CD25  17 ± 1 18 ± 3 17 ± 2 16 ± 2
aClean air.
Table 5. Expression of receptors on AMs from individuals exposed to CAPS. 
Percent of gated macrophages
Receptor Quartile 1 Quartile 2 Quartile 3 Quartile 4
CD11b 41 ± 6  43 ± 9 46 ± 9 44 ± 6
CD14 119 ± 20  97 ± 23 134 ± 23 133 ± 33
CD16 259 ± 70  192 ± 80 277 ± 117 434 ± 152
CD64 84 ± 12  114 ± 18 89 ± 20 121 ± 19
Table 6. Phagocytosis and oxidant generation by AMs following CAPs exposure.
Percent of phagocytic cells
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Zymosan 60 ± 4  62 ± 5  55 ± 5  58 ± 6
Streptococcus 88 ± 4  89 ± 3  89 ± 2  85 ± 5
Chemiluminescence 820 ± 130  1056 ± 195  833 ± 115  1478 ± 722
(integrated cpm × 105)
cpm, counts per minute.Concentrated ambient particles and humans
following diesel exhaust exposure vs 18 hr
following CAPS exposure), or discrepancies
in the total particle dose delivered to the
lung in the two studies.
Acute exposure to CAPS did not affect
macrophage surface receptor expression or
phagocytic function. This may not be surpris-
ing, as PM2.5 did not affect AM receptor
expression and function when these cells were
stimulated in vitro with the ﬁne PM fraction.
Our previous studies have shown that parti-
cles in the coarse PM2.5–10 fraction alter the
phenotype and phagocytic capability of these
cells. PM2.5 assessed simultaneously had no
effect on phagocytosis or oxidant generation
(13,15). Similarly, host defenses of mice
exposed to PM2.5 and PM2.5–10 were found
to be altered by PM2.5–10 but not PM2.5 (21).
Therefore, it is possible that PM2.5 are more
active in affecting mortality and health end
points depending on cardiac function (22)
than in altering host defenses. The possibility
also exists that a different PM2.5 exposure or
sampling time may result in different find-
ings. Future studies will deal with the in vivo
role of coarse particles in affecting human
lung host defense and immune function, in a
similar study protocol as presented here.
From the lack of effects of CAPS on the
makeup of lymphocyte population in the
lung, it is concluded that short-term inhala-
tion of PM2.5 may not alter local immune
capability. Furthermore, there was no change
in the leukocyte composition in the blood.
Some components likely to be present in
CAPs have been shown to affect lymphocyte
inﬂux into the lung. In a recent study, solu-
ble components of Utah Valley PM were seg-
mentally instilled into healthy volunteers,
and this resulted in an increase in CD4-
positive lymphocytes in the lung, as well as
an increase in activated CD25, CD69 posi-
tive cells (23). The effect could not be
ascribed to total soluble metals in the PM.
The proinﬂammatory and immune modula-
tory components in the Utah PM remain
unidentified. The local concentration of the
Utah PM extract following segmental instil-
lation certainly was much higher than can be
expected in the present study. CAPS of the
PM2.5 fraction also contain diesel soot which
has been shown to induce B-cell activation
and the production of immunoglobulin E
(10). Phenotyping T-cell subsets and B cells
would not reveal this stimulation, although
one could expect an increase in cells with a
stimulated phenotype, i.e., CD69 expression.
The evidence for changes in immune func-
tion following acute particle inhalation is
scarce. Salvi et al. (7) found a significant
increase in CD4 and CD8 cells in the air-
ways mucosa 6 hr following inhalation of
diesel exhaust for 1 hr. B cells were also
increased in the airways. Events following
cigarette smoke inhalation may also reflect
responses to pollution particles. In a study
where cigarette smoke was acutely inhaled, a
transient rise in leukocytes and neutrophil acti-
vation was found (24,25). In the blood follow-
ing CAPS inhalation there was no evidence of
bone marrow stimulation, as total leukocyte
cell counts and cell differentials were unaf-
fected. The blood neutrophils did not show
activation in the chemiluminescence assay.
This study has demonstrated that inhalation
of moderate levels of PM2.5 has little acute
effect on the human host defenses, including
immune activation and lung macrophage
function under the conditions tested. The
study population was young and healthy, while
effects on particles have been implicated in
individuals with preexisting respiratory prob-
lems including asthma and serious lung infec-
tions. These individuals already are in a state of
immune activation so that cellular inﬂamma-
tion in the respiratory tract with activated and
inﬂammatory cells may be more susceptible to
toxic insult than resting cells. Future studies
will aim to enroll subjects with mild to moder-
ate respiratory disease to resolve the question of
possible immune dysfunction and will include
additional associated biomarkers.
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